Silk Road Medical (NASDAQ:SILK – Free Report) had its target price boosted by JPMorgan Chase & Co. from $19.00 to $21.00 in a research note issued to investors on Wednesday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. Other research analysts also recently issued reports about the company. […]
Silk Road Medical (NASDAQ:SILK – Free Report) had its price target lifted by JPMorgan Chase & Co. from $19.00 to $21.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a neutral rating on the stock. Several other equities analysts also recently weighed in on SILK. Stifel Nicolaus raised […]
Silk Road Medical (NASDAQ:SILK – Get Free Report) released its earnings results on Tuesday. The company reported ($0.36) EPS for the quarter, topping the consensus estimate of ($0.40) by $0.04, Briefing.com reports. Silk Road Medical had a negative return on equity of 35.12% and a negative net margin of 29.02%. The business had revenue of […]
Silk Road Medical (NASDAQ:SILK – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.36) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.40) by $0.04, Briefing.com reports. Silk Road Medical had a negative return on equity of 36.38% and a negative net margin of 31.70%. The […]
Silk Road Medical (NASDAQ:SILK – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.36) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.40) by $0.04, Briefing.com reports. Silk Road Medical had a negative net margin of 31.70% and a negative return on equity of 36.38%. The company […]